{'fraction_non_alphanumeric': 0.048801958090003435, 'fraction_numerical': 0.03931209206458262, 'mean_word_length': 4.318830649765902, 'pattern_counts': {'":': 0, '<': 8, '<?xml version=': 0, '>': 1, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 1, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Rosmarinic Acid and Sodium Citrate Have a Synergistic Bacteriostatic Effect against Vibrio Species by Inhibiting Iron Uptake

Background: New strategies are needed to combat multidrug-resistant bacteria. The restriction of iron uptake by bacteria is a promising way to inhibit their growth. We aimed to suppress the growth of Vibrio bacterial species by inhibiting their ferric ion-binding protein (FbpA) using food components. Methods: Twenty spices were selected for the screening of FbpA inhibitors. The candidate was applied to antibacterial tests, and the mechanism was further studied. Results: An active compound, rosmarinic acid (RA), was screened out. RA binds competitively and more tightly than Fe3+ to VmFbpA, the FbpA from V. metschnikovii, with apparent KD values of 8 μM vs. 17 μM. Moreover, RA can inhibit the growth of V. metschnikovii to one-third of the control at 1000 μM. Interestingly, sodium citrate (SC) enhances the growth inhibition effect of RA, although SC only does not inhibit the growth. The combination of RA/SC completely inhibits the growth of not only V. metschnikovii at 100/100 μM but also the vibriosis-causative pathogens V. vulnificus and V. parahaemolyticus, at 100/100 and 1000/100 μM, respectively. However, RA/SC does not affect the growth of Escherichia coli. Conclusions: RA/SC is a potential bacteriostatic agent against Vibrio species while causing little damage to indigenous gastrointestinal bacteria.


Introduction
Vibrio is a genus of ubiquitous bacteria that inhabit a wide range of aquatic and marine environments and cause seafood contamination and infectious diseases in humans. More than 30 species of Vibrio have been discovered to date and V. cholerae, V. parahaemolyticus, V. alginolyticus, V. vulnificus, V. fluvialis, V. hollisaea, V. mimicus, and V. metschnikovii are among the most frequently isolated human pathogens. These bacteria are found in environments of moderate or high salinity, including in seawater and seafood, and they are agents of human vibriosis [1].
Sushi is a Japanese cuisine that is popular worldwide. People consume a large number of raw marine fishes, crustaceans, and shellfishes as sushi with soy sauce. However, eating raw seafood contaminated by microorganisms may cause disease; indeed, Vibrio-related seafood-borne diseases are rapidly increasing [2]. According to the Intergovernmental Panel on Climate Change (IPCC), on a global scale, the ocean surface is warming due to Here, we report a natural inhibitor of VmFbpA from rosemary extract, rosmarinic acid (RA), which was screened out from 20 spices, and show that its antibacterial effect on several Vibrio species is enhanced in the presence of sodium citrate (SC).

Screening of VmFbpA Inhibitors from Aqueous Extracts of 20 Spices
Assays for the inhibition of Fe 3+ binding of VmFbpA were performed, and the remaining Fe concentrations were measured via ICP-MS using aqueous extracts of 20 spices at a final concentration of 2.5 mg/mL (Figure 1a). Only cinnamon and rosemary extracts decreased the remaining Fe concentration by more than 50% compared to the Fe 3+ -VmFbpA control group. Furthermore, no spice extracts increased the remaining Fe concentration higher than the Fe 3+ -VmFbpA control group. Therefore, cinnamon and rosemary extracts were considered candidate inhibitors of VmFbpA.

Spectral Analysis of VmFbpA Interacting with RA
To assess their dose-dependent effects on the inhibition of Fe 3+ binding by VmFbpA, different concentrations (0, 0.9, 1.9, 3.8, 7.5, and 15 mg/mL) of cinnamon and rosemary extracts were subjected to inhibition assays using UV-visible absorbance spectroscopy (Figure 1b-e). In the case of cinnamon extracts, the color of the eluents changed from yellow to colorless and finally became dark red as the applied concentration increased (Figure 1b). In the case of rosemary extracts, the color of the eluents changed from yellow to colorless and finally became yellow again (this yellow color is the color from rosemary extracts but not Fe 3+ ) as the applied concentration increased (Figure 1d). A significant peak shift (from ≈412 nm to ≈380 nm) was observed in the spectra of the samples treated with rosemary extracts (Figure 1e). However, no such peak shift was observed in the samples treated with cinnamon extracts (Figure 1c). Consequently, rosemary extracts were selected for further analysis.
Second, a major component of rosemary extract, RA (0, 0.15, 0.30, 0.60, 1.2, and 2.4 mg/mL), was subjected to an inhibition assay. Compared to the spectrum of VmFbpA or RA only, that of VmFbpA mixed with RA showed a specific peak (Figure 1f,g). In addition, a similar peak shift (from ≈412 nm to 380 nm) to that caused by the rosemary extract was observed (Figure 1e).
The affinity between RA/Fe 3+ and VmFbpA was measured via ITC (Figure 3a-c). The best fit of the ITC data in Figure 3a was attained with a single-site model; the apparent association constant (KA, app) was 1.3 × 10 5 ± 0.2 × 10 4 M -1 . The apparent KD of RA binding to VmFbpA was ≈8 μM (Figure 3a), which is two-fold stronger than Fe 3+ binding to VmFbpA (apparent KD ≈ 17 μM) (Figure 3c). However, a more complicated curve was obtained for ITC experiments using Fe 3+ -VmFbpA, which could not be fit to any model (Figure 3b). The thermodynamic parameters for the reaction between RA and apo VmFbpA were ΔH = −15 ± 9 kcal/mol and ΔS = −0.04 ± 0.03 kcal/mol/deg, which are shown in Figure  3d.  The affinity between RA/Fe 3+ and VmFbpA was measured via ITC (Figure 3a-c). The best fit of the ITC data in Figure 3a was attained with a single-site model; the apparent association constant (K A, app ) was 1.3 × 10 5 ± 0.2 × 10 4 M −1 . The apparent K D of RA binding to VmFbpA was ≈8 µM (Figure 3a), which is two-fold stronger than Fe 3+ binding to VmFbpA (apparent K D ≈ 17 µM) (Figure 3c). However, a more complicated curve was obtained for ITC experiments using Fe 3+ -VmFbpA, which could not be fit to any model ( Figure 3b). The thermodynamic parameters for the reaction between RA and apo VmFbpA were ∆H = −15 ± 9 kcal/mol and ∆S = −0.04 ± 0.03 kcal/mol/deg, which are shown in Figure 3d.

Spectra Analysis of Fe 3+ Interacting with RA
The interactions between RA and Fe 3+ were also investigated ( Figure S3), including the UV-visible absorbance spectra of RA supplemented with different concentrations of FeCl3 ( Figure S3a). After subtraction of the respective FeCl3 spectra ( Figure S3b), the net spectra were obtained ( Figure S3c). The net spectra showed two peaks (≈290 nm and ≈320 nm) in the spectrum of 20 μM RA, whereas only one peak at ≈250 nm was observed with supplementation of 20, 30, and 40 μM FeCl3. Moreover, the spectrum of 20 μM RA with supplementation of 10 μM FeCl3 showed an intermediate pattern during the peak shift from ≈290 nm and ≈320 nm to ≈250 nm.

Inhibition of Bacterial Growth by RA
The bacteriostatic effect of RA on the growth of V. metschnikovii was assayed ( Figure  4). The growth of V. metschnikovii in nutrient broth (NB) medium leads to a final OD600 value of ≈0.6 after 5 h using a microplate spectrophotometer (Benchmark Plus, Bio-Rad).
In the presence of 500 μM RA, the final OD600 value decreased to about one-half of the control group. In the presence of 1000 μM RA, the final OD600 value decreased to about one-quarter of the control group (Figure 4a). The OD600 value at 7 h was used for statistical

Spectra Analysis of Fe 3+ Interacting with RA
The interactions between RA and Fe 3+ were also investigated ( Figure S3), including the UV-visible absorbance spectra of RA supplemented with different concentrations of FeCl 3 ( Figure S3a). After subtraction of the respective FeCl 3 spectra ( Figure S3b), the net spectra were obtained ( Figure S3c). The net spectra showed two peaks (≈290 nm and ≈320 nm) in the spectrum of 20 µM RA, whereas only one peak at ≈250 nm was observed with supplementation of 20, 30, and 40 µM FeCl 3 . Moreover, the spectrum of 20 µM RA with supplementation of 10 µM FeCl 3 showed an intermediate pattern during the peak shift from ≈290 nm and ≈320 nm to ≈250 nm.

Inhibition of Bacterial Growth by RA
The bacteriostatic effect of RA on the growth of V. metschnikovii was assayed ( Figure 4). The growth of V. metschnikovii in nutrient broth (NB) medium leads to a final OD 600 value of ≈0.6 after 5 h using a microplate spectrophotometer (Benchmark Plus, Bio-Rad). In the presence of 500 µM RA, the final OD 600 value decreased to about one-half of the control group. In the presence of 1000 µM RA, the final OD 600 value decreased to about one-quarter of the control group (Figure 4a). The OD 600 value at 7 h was used for statistical analysis. In the presence of 100 µM RA, the OD 600 value at 7 h showed a statistically significant decrease (p = 0.026) compared to the control group. The OD 600 value at 7 h further decreased as the RA concentration increased to 500 µM and 1000 µM. In the presence of 500 µM RA, the OD 600 value at 7 h decreased to ≈0.4 (p < 0.001) and in the presence of 1000 µM RA, the OD 600 value at 7 h decreased to ≈0.18 (p < 0.001) (Figure 4b). The growth of E. coli BL21(DE3) and KRX in NB medium leads to a final OD600 value of ≈0.8 after 5 h using a microplate spectrophotometer (Benchmark Plus, Bio-Rad, Hercules, CA, USA). However, the OD600 value and the bacterial growth curve were not affected by RA at 25 μM to 1000 μM (Figure 4c,d).

Iron Utilization in V. Metschnikovii
The weight of V. metschnikovii after 7 h culture in NB medium decreased with increasing RA concentration (Figure 5a). The iron consumed by V. metschnikovii in all samples showed the same tendency, as measured using ICP-MS. The Fe utilization ratio decreased to half of the initial value after adding 100 μM RA (p = 0.05) and further decreased to a quarter as the RA concentration increased to 1000 μM (p < 0.01) (Figure 5b). The recovery of V. metschnikovii in the presence of 1000 μM RA was investigated by supplementation of 10 and 50 μmol FeCl3 to final concentrations of 1 μM and 5 μM. When V. metschnikovii was supplemented with 1 μM FeCl3, slight recovery was observed, whereas after supplementation with 5 μM FeCl3, the recovery of V. metschnikovii was more obvious (Figure 5c). Based on the OD600 value at 7 h, the groups supplemented with 1 μM (p < 0.01) and 5 μM FeCl3 (p < 0.001) were significantly different from the negative control ( Figure 5d). The growth of E. coli BL21(DE3) and KRX in NB medium leads to a final OD 600 value of ≈0.8 after 5 h using a microplate spectrophotometer (Benchmark Plus, Bio-Rad, Hercules, CA, USA). However, the OD 600 value and the bacterial growth curve were not affected by RA at 25 µM to 1000 µM (Figure 4c,d).

Iron Utilization in V. metschnikovii
The weight of V. metschnikovii after 7 h culture in NB medium decreased with increasing RA concentration ( Figure 5a). The iron consumed by V. metschnikovii in all samples showed the same tendency, as measured using ICP-MS. The Fe utilization ratio decreased to half of the initial value after adding 100 µM RA (p = 0.05) and further decreased to a quarter as the RA concentration increased to 1000 µM (p < 0.01) (Figure 5b). The recovery of V. metschnikovii in the presence of 1000 µM RA was investigated by supplementation of 10 and 50 µmol FeCl 3 to final concentrations of 1 µM and 5 µM. When V. metschnikovii was supplemented with 1 µM FeCl 3 , slight recovery was observed, whereas after supplementation with 5 µM FeCl 3 , the recovery of V. metschnikovii was more obvious (Figure 5c). Based on the OD 600 value at 7 h, the groups supplemented with 1 µM (p < 0.01) and 5 µM FeCl 3 (p < 0.001) were significantly different from the negative control ( Figure 5d).

Inhibition by RA and Sodium Citrate (SC) of the Growth of V. metschnikovii
The growth of V. metschnikovii was inhibited to ≈70% by 1000 μM RA, and this inhibition was enhanced by 10, 100, and 1000 μM SC ( Figure 6a). Interestingly, the growth of V. metschnikovii was hardly inhibited by 10, 100, and 1000 μM SC without adding 1000 μM RA. The recovery of V. metschnikovii growth was observed as the RA concentration decreased from 1000 to 25 μM RA in the presence of 100 μM SC (Figure 6b).

Inhibition by RA and Sodium Citrate (SC) of the Growth of V. metschnikovii
The growth of V. metschnikovii was inhibited to ≈70% by 1000 µM RA, and this inhibition was enhanced by 10, 100, and 1000 µM SC ( Figure 6a). Interestingly, the growth of V. metschnikovii was hardly inhibited by 10, 100, and 1000 µM SC without adding 1000 µM RA. The recovery of V. metschnikovii growth was observed as the RA concentration decreased from 1000 to 25 µM RA in the presence of 100 µM SC (Figure 6b).
The addition of RA or using the combination of RA and SC did not have a significant inhibitory effect on E. coli growth; all of the E. coli groups had an OD 600 value of ≈0.8 after incubation for 7 h in NB medium (Figure 6c The addition of RA or using the combination of RA and SC did not have a significant inhibitory effect on E. coli growth; all of the E. coli groups had an OD600 value of ≈0.8 after incubation for 7 h in NB medium (Figure 6c,d).

Mechanism of RA Binding to VmFbpA
The crystal structure of apo VmFbpA was determined by X-ray crystallography (Figure S4). Diffraction-quality crystals of apo VmFbpA were obtained with a reservoir composition of 0.25 M ammonium tartrate dibasic, 25% PEG3350, 100 mM Tris-HCl (pH 7.0). The apo VmFbpA crystal belonged to space group P6322, with unit-cell parameters a = 90.79, b = 90.79, and c = 149.68 (Table S1). The crystal structure of apo VmFbpA was determined at 1.86 Å resolution by molecular replacement using the structure of TtFbpA (PDB entry 3WAE) as the search model. The final structure of apo VmFbpA contained one monomeric VmFbpA molecule (residues 1-309) and 238 water molecules in the asymmetric unit. Data collection and refinement statistics are summarized in Table S1. The Ramachandran plot of the apo VmFbpA structure shows that 99.35% and 0.65% of the residues are in the most favored and allowed regions, respectively. Second, the binding and inhibiting models were simulated in silico by docking analysis using Autodock vina. Three areas were selected as the potential docking regions for VmFbpA binding, namely C-Lobe, N-Lobe, and Fe 3+ binding site ( Figure S5). The ΔG value for each model docking at the C-

Mechanism of RA Binding to VmFbpA
The crystal structure of apo VmFbpA was determined by X-ray crystallography ( Figure S4). Diffraction-quality crystals of apo VmFbpA were obtained with a reservoir composition of 0.25 M ammonium tartrate dibasic, 25% PEG3350, 100 mM Tris-HCl (pH 7.0). The apo VmFbpA crystal belonged to space group P6 3 22, with unit-cell parameters a = 90.79, b = 90.79, and c = 149.68 (Table S1). The crystal structure of apo VmFbpA was determined at 1.86 Å resolution by molecular replacement using the structure of TtFbpA (PDB entry 3WAE) as the search model. The final structure of apo VmFbpA contained one monomeric VmFbpA molecule (residues 1-309) and 238 water molecules in the asymmetric unit. Data collection and refinement statistics are summarized in Table S1. The Ramachandran plot of the apo VmFbpA structure shows that 99.35% and 0.65% of the residues are in the most favored and allowed regions, respectively. Second, the binding and inhibiting models were simulated in silico by docking analysis using Autodock vina. Three areas were selected as the potential docking regions for VmFbpA binding, namely C-Lobe, N-Lobe, and Fe 3+ binding site ( Figure S5). The ∆G value for each model docking at the C-Lobe and N-Lobe was 0.0 kcal/mol, whereas the ∆G value for the best model docking at the Fe 3+ binding site was ≈−7.0 kcal/mol, indicating that RA binds VmFbpA at the Fe 3+ binding site rather than C-Lobe and N-Lobe (Table S2).
Inside the Fe 3+ binding site, a total of nine models was presented by AutoDock (version Vina 1.1.2) (Figure 7, Table S3). In Model 1, six hydrogen bonds were formed between RA and VmFbpA. Amino acid residues R9, G140, N193, and V259 were involved in the interaction (Figure 7a). In Model 2, eight hydrogen bonds were formed between RA and VmFbpA. Amino acid residues R9, G34, D35, T36, Q58, and Y196 were involved in the interaction (Figure 7b). In Model 3, seven hydrogen bonds were formed between RA and VmFbpA. Amino acid residues R9, Q58, G140, N193, Y195, and Y196 were involved in the interaction (Figure 7c). In Model 4, six hydrogen bonds were formed between RA and VmFbpA. Amino acid residues R9, N138, N193, and Y196 were involved in the interaction (Figure 7d). In Model 5, four hydrogen bonds were formed between RA and VmFbpA. Amino acid residues R9, Q58, and R100 were involved in the interaction (Figure 7e). In Model 6, six hydrogen bonds were formed between RA and VmFbpA. Amino acid residues R9, R100, Y196, and E262 were involved in the interaction (Figure 7f). In Model 7, six hydrogen bonds were formed between RA and VmFbpA. Amino acid residues Q58, Y195, and R199 were involved in the interaction (Figure 7g). In Model 8, four hydrogen bonds were formed between RA and VmFbpA. Amino acid residues Q58, N193, Y195, and E262 were involved in the interaction (Figure 7h). In Model 9, four hydrogen bonds were formed between RA and VmFbpA. Amino acid residues R9, Q58, N193, and E262 were involved in the interaction (Figure 7i).
Lobe and N-Lobe was 0.0 kcal/mol, whereas the ΔG value for the best model docking at the Fe 3+ binding site was ≈-7.0 kcal/mol, indicating that RA binds VmFbpA at the Fe 3+ binding site rather than C-Lobe and N-Lobe (Table S2).
Inside the Fe 3+ binding site, a total of nine models was presented by AutoDock (version Vina 1.1.2) (Figure 7, Table S3). In Model 1, six hydrogen bonds were formed between RA and VmFbpA. Amino acid residues R9, G140, N193, and V259 were involved in the interaction (Figure 7a). In Model 2, eight hydrogen bonds were formed between RA and VmFbpA. Amino acid residues R9, G34, D35, T36, Q58, and Y196 were involved in the interaction (Figure 7b). In Model 3, seven hydrogen bonds were formed between RA and VmFbpA. Amino acid residues R9, Q58, G140, N193, Y195, and Y196 were involved in the interaction (Figure 7c). In Model 4, six hydrogen bonds were formed between RA and VmFbpA. Amino acid residues R9, N138, N193, and Y196 were involved in the interaction (Figure 7d). In Model 5, four hydrogen bonds were formed between RA and VmFbpA. Amino acid residues R9, Q58, and R100 were involved in the interaction (Figure 7e). In Model 6, six hydrogen bonds were formed between RA and VmFbpA. Amino acid residues R9, R100, Y196, and E262 were involved in the interaction (Figure 7f). In Model 7, six hydrogen bonds were formed between RA and VmFbpA. Amino acid residues Q58, Y195, and R199 were involved in the interaction (Figure 7g). In Model 8, four hydrogen bonds were formed between RA and VmFbpA. Amino acid residues Q58, N193, Y195, and E262 were involved in the interaction (Figure 7h). In Model 9, four hydrogen bonds were formed between RA and VmFbpA. Amino acid residues R9, Q58, N193, and E262 were involved in the interaction (Figure 7i).   (Figure 8a). However, at 1000 mM RA, the growth of both V. vulnificus and V. parahaemolyticus was almost completely inhibited (Figure 8b).

Inhibition by RA and SC of the Growth of V. vulnificus and V. parahaemolyticus
To assess the bacteriostatic effects of RA and SC on other Vibrio species, V. parahaemolyticus (which causes the most Vibrio infections in the US) and V. vulnificus (which is the most life-threatening non-cholera Vibrio bacterium), were used. V. vulnificus was almost completely inhibited by 100 mM RA and 100 mM SC, whereas V. parahaemolyticus was resistant to the same condition (Figure 8a). However, at 1000 mM RA, the growth of both V. vulnificus and V. parahaemolyticus was almost completely inhibited (Figure 8b).

Screening and Identification of RA as a VmFbpA Inhibitor
Fe concentration was quantified via a VmFbpA inhibitor screening assay using ICP-MS. Rosemary and cinnamon extracts decreased Fe concentrations to almost half of that in the Holo group (Fe 3+ -VmFbpA, positive control) (Figure 1a). UV-vis spectral analysis indicated a changed spectral pattern in samples treated with rosemary and cinnamon (Figure 1c,e). A significant peak shift (from ≈412 to ≈380 nm) in the UV-vis spectra was observed in samples treated with rosemary extracts (Figure 1e) but not in those treated with cinnamon extracts (Figure 1c). This indicates that the chemicals in the rosemary extracts interact with or bind to VmFbpA. By contrast, the interaction between cinnamon extracts and VmFbpA may be nonspecific.
In rosemary, the most frequently reported functional chemical is RA, which is the main active phenolic compound and has antibacterial activity [16]. Consequently, a spectral analysis of apo VmFbpA supplemented with RA was performed (Figure 1f). The same

Screening and Identification of RA as a VmFbpA Inhibitor
Fe concentration was quantified via a VmFbpA inhibitor screening assay using ICP-MS. Rosemary and cinnamon extracts decreased Fe concentrations to almost half of that in the Holo group (Fe 3+ -VmFbpA, positive control) (Figure 1a). UV-vis spectral analysis indicated a changed spectral pattern in samples treated with rosemary and cinnamon (Figure 1c,e). A significant peak shift (from ≈412 to ≈380 nm) in the UV-vis spectra was observed in samples treated with rosemary extracts (Figure 1e) but not in those treated with cinnamon extracts (Figure 1c). This indicates that the chemicals in the rosemary extracts interact with or bind to VmFbpA. By contrast, the interaction between cinnamon extracts and VmFbpA may be nonspecific.
In rosemary, the most frequently reported functional chemical is RA, which is the main active phenolic compound and has antibacterial activity [16]. Consequently, a spectral analysis of apo VmFbpA supplemented with RA was performed (Figure 1f). The same peak shift (from ≈412 to ≈380 nm) as for rosemary extracts was observed. Therefore, the functional chemical that specifically interacts with VmFbpA was RA.
In the spectra of RA only (Figure 1g), no specific peak at ≈380 nm was observed. This demonstrated that the peak at ≈380 nm was a result of binding between VmFbpA and RA but not RA itself (Figure 1f,g).

Interaction between RA and VmFbpA
The ITC results demonstrated that the interaction between RA and apo VmFbpA takes place at a single site 1:1 binding with a K D value of 8 ± 1 µM (Figure 3a), which could be presented as below: Based on the thermodynamic parameters obtained from the ITC results, ∆G for Reaction I at 298 K is −5 ± 2 kcal/mol, indicating that Reaction I can progress spontaneously without external energy (Figure 3d). Furthermore, the ∆H and −T∆S for Reaction I were −15 ± 9 kcal/mol and 11 ± 8 kcal/mol, respectively, indicating that Reaction I was driven by enthalpy but not entropy and hydrogen bonds were the main interactions [17,18] between RA and VmFbpA (Figure 3d).
The interaction between RA and Fe 3+ -VmFbpA was more complicated (Figure 3b). In the first four titrations, the heat change (µcal/s) experienced a decrease to a negative value (an exothermic reaction), which was followed by an increase to a positive value (an endothermic reaction), so that the net heat change was zero. An exothermic reaction was observed from the fifth to the eleventh titration, after which VmFbpA became saturated. The fact that an exothermic reaction followed by an endothermic reaction was observed in the first four titrations is a result of complex interactions among Fe 3+ , VmFbpA, and RA. These interactions could include binding between RA and VmFbpA (exothermic reaction), binding between Fe 3+ and VmFbpA (endothermic reaction) (Figure 3c) [19], and reduction of Fe 3+ to Fe 2+ by RA (Figure 2e). A significant heat difference was observed only when the molar ratio of RA: Fe 3+ -VmFbpA was higher than 2:1, indicating that RA binds to VmFbpA competitively at the Fe 3+ binding site and Fe 3+ -VmFbpA has some resistance to RA at low concentrations.
Docking results showed that RA binds VmFbpA at the Fe 3+ binding site (∆G ≈ −7.0 kcal/mol) ( Figure S4d, Table S2) rather than the C-Lobe and N-Lobe (∆G ≈ 0.0 kcal/mol). The in silico theoretical K D value between RA and apo VmFbpA is ≈7.1 µM at room temperature, which is consistent with the in vitro ITC results. In the docking model, RA formed many hydrogen bonds with VmFbpA (Figure 7), indicating that the interaction between RA and VmFbpA is driven by enthalpy but not entropy, as described in the analysis of ITC results.

Interaction between RA and Fe 3+
The net spectra of RA in the presence of Fe 3+ indicated that RA interacts with Fe 3+ (Figure S3c), and the iron reduction experiments showed that RA can reduce Fe 3+ to Fe 2+ (Figure 2e,f). RA is an effective antioxidant, showing DPPH scavenging [20], ABTS(+) scavenging [21], and other activities. However, our results suggest that the antioxidant activity of RA is strong enough to reduce Fe 3+ to Fe 2+ , which is consistent with a report that RA and its derivatives can reduce the Fe 3+ in ferric 2,4,6-tris(2-pyridyl)-s-triazine (TPTZ) to Fe 2+ to a colored product [22]. Therefore, Fe 3+ release from VmFbpA by RA was in part caused by the competitive inhibition of VmFbpA and by the reduction of Fe 3+ to Fe 2+ . The regression curve showed that 1 µM RA can reduce ≈2.44 µM Fe 3+ to Fe 2+ (Figure 2f), indicating that the stoichiometry of the reaction between RA and Fe 3+ is approximately 1:2 and one RA molecule can reduce about two Fe 3+ to Fe 2+ (Figure 2f).

Inhibition of V. metschnikovii Growth by RA
The growth of V. metschnikovii was significantly inhibited by RA in a dose-dependent manner (Figure 4a). This is probably because the iron-capturing protein, VmFbpA, was inhibited by RA (Figure 2c,d), and Fe utilization in V. metschnikovii is significantly lowered (Figure 5b). The recovery experiments showed that the bactericidal activity of RA against V. metschnikovii resulted from the restriction of iron uptake, because the growth of V. metschnikovii was recovered after adding 5 µmol FeCl 3 (Figure 5c,d).
E. coli is the most abundant bacterium in the human colon. Therefore, we evaluated the growth of E. coli with the supplementation of RA. E. coli was not significantly inhibited by RA (Figure 4c,d). Similarly, it has been reported that E. coli is more resistant to rosemary extracts and RA than other Gram-negative bacteria [16]. Moreover, E. coli can use a wide range of iron sources, for instance, ferric ammonium citrate, hematin hydrochloride, lysed guinea-pig red cells, crystalline human hemoglobin [23], and ferrous ion [24]. Therefore, even if FbpA, the Fe 3+ capturing protein, is inhibited, E. coli could use other iron sources for growth (Table 1). Additionally, it is important to note that the pH of the NB medium did not change significantly after adding RA and SC ( Figure S7). Therefore, it is not the pH change that affects the growth of bacteria.

Effect of RA Combined with SC on Bacterial Growth
RA (1000 µM) inhibited the growth of V. metschnikovii to ≈65% (Figure 4a,b), and the inhibition was enhanced to >90% by adding SC (Figure 6a,b). However, RA did not significantly inhibit E. coli growth (Figure 4c,d), nor did the combination of RA and SC (Figure 6c,d). These results indicate that E. coli uses a variety of iron sources and is resistant to RA and SC, but V. metschnikovii is more vulnerable to RA in the presence of SC. E. coli and V. metschnikovii have an FbpBC/A uptake system to take up Fe 3+ , which is a common means of absorbing iron (Table 1). Under anaerobic, low pH, or reducing conditions, iron is mainly present as Fe 2+ [25]. E. coli has evolved diverse transporter systems (FeoABC [27], EfeOUB [24], and MntH [28]) to absorb Fe 2+ , whereas V. metschnikovii has only an FeoABC system (Table 1).
Interestingly, E. coli responds to iron restriction by producing citrate [30,31] and has an Fec(CD)E/A transporter system for ferric citrate uptake [29], which is absent in V. metschnikovii (Table 1). Furthermore, FecB, the periplasmic subunit of the Fec(CD)E/B system, binds a variety of Fe-citrate complexes (citrate, Fe 3+ -Cit, [Fe 2 (Cit 2 )] 2-, and [Fe(Cit) 2 ] 5-) as well as other citrate complexes (Ga 3+ , Al 3+ , Sc 3+ , In 3+ , and Mg 2+ ) with a K d value in the micromolar range [29]. When FbpAs in E. coli and V. metschnikovii were inhibited by 1000 µM RA, Fe 3+ was reduced to Fe 2+ . Subsequently, adding citrate chelates free Fe 2+ into Fe 2+ -citrate complexes. These Fe 2+ -citrate complexes can be taken up by E. coli via the Fec(CD)E/B transporter system, whereas the Fe 2+ -citrate complexes are not bioavailable for V. metschnikovii. This could be why E. coli is more resistant to RA and the combination of RA and SC than V. metschnikovii. Therefore, RA combined with SC could inhibit V. metschnikovii without deleterious effects on indigenous gastrointestinal bacteria.
Moreover, the following reasons may explain why SC did not affect the growth of V. metschnikovii. SC chelates Fe 3+ to Fe 3+ -citrate complexes, but V. metschnikovii has a siderophore-based CeuBC/A transporter that is responsible for Fe 3+ -enterochelin uptake (Table 1). V. metschnikovii releases the siderophore enterochelin to absorb Fe 3+ under ironrestricted conditions. Enterochelin is the strongest siderophore and binds to Fe 3+ with extremely strong affinity (Ka = 10 52 M −1 ) [32]. This value is substantially higher than even several synthetic metal chelators, such as EDTA (Ka = 10 25 M −1 ) [33]. Therefore, without RA, Fe 3+ was not reduced to Fe 2+ . If Fe 3+ is chelated by citrate, it can be reclaimed by enterochelin. This explains why the growth of V. metschnikovii was not affected by SC alone.
Considering the future potential applications of VmFbpA inhibitors, we conducted an alignment of VmFbpA to other FbpAs from pathogenic Vibrio species. Since we focused on non-cholera Vibrio infections in this study, V. vulnificus and V. parahaemolyticus were selected for the further antibacterial experiments. The results showed that FbpA is a highly conserved protein with a sequence identity of ≈31% ( Figure S6, Table S4). Bacteriostatic experiments ( Figure 5) on V. vulnificus and V. parahaemolyticus indicated that RA combined with SC can also inhibit the growth of these infectious Vibrio by limiting Fe 3+ uptake. Based on the knowledge iron uptake proteins in Vibrio bacteria, the RA/SC would be further effective in suppressing the growth of V. cholerae, although it needs to be confirmed.
Additionally, the results from a pilot experiment performed in Japan several decades ago support our experimental data [34]. The traditional Japanese food "umeboshi" is made with shiso (perilla; Perilla frutescens var. crispa) and ume (salted Japanese plum; Prunus mume Sieb. et Zucc.), which contain RA and SC, respectively. Due to its antibacterial properties, umeboshi was traditionally used as a medicine in the middle and early modern ages and is currently used as a natural preservative to prevent the spoilage of items in lunch boxes and rice balls. In the 19th and early 20th centuries, umeboshi was found to be an effective treatment for cholera and was used as an anti-cholera medicine in Japan. Tetsumoto (1934) found that umeboshi exhibited strong bactericidal activity against V. cholerae, as compared to citric acid, which has a similar pH [34]. Our data presented here suggest that RA and SC are among the anti-cholera components in umeboshi. Here, we propose that the anti-cholera activity of umeboshi could be exerted mainly or partly by inhibiting the iron uptake by V. cholerae, although it needs to be confirmed by further experiments.

Chemicals and Materials
RA (98% pure, CAS: 20283-92-5) was purchased from Combi-Blocks (San Diego, CA, USA). All other reagents used in this study were purchased from Fujifilm Wako Pure Chemical Co., Ltd. (Osaka, Japan) unless otherwise stated.
Vibrio species (V. metschnikovii, V. vulnificus, and V. parahaemolyticus) were obtained from Japan Collection of Microorganisms, RIKEN (Ibaraki, Japan) and were handled in a safety cabinet to avoid contamination. All E. coli strains (BL21(DE3) and KRX) were purchased from Novagen (Madison, WI, USA) and Promega (Madison, WI, USA), respectively, and were handled in a clean bench to avoid contamination.

Aqueous Extracts of Spices
A total of 0.50 g (±0.01) of each spice was ground into powder, extracted in 20 mL boiling Milli-Q (Milli-Q Advantage), and incubated in a water bath at 95 • C for 3 h. The insoluble fraction was removed using a 0.45 µm polyethersulfone (PES) filter. The filtrate was evaporated to powder and stored at −30 • C.

Expression and Purification of 6× His-tev-VmFbpA
The gene encoding VmFbpA (WP_004394209.1) without the signal peptide 'MQKKLL-STVALVSSLITAPLLHA' was cloned into a modified pET-28a vector, where the thrombin cleavage site had been replaced by a TEV cleavage site, and overexpressed in E. coli BL21(DE3). Large-scale overexpression of 6× His-tev-VmFbpA was performed at 30 • C in 2 L of LB medium with isopropyl β-D-1-thiogalactopyranoside (final concentration 0.001 mM) at an OD 600 of about 0.6. After the induction, the cells were cultivated at 30 • C for 20 h and harvested by centrifugation at 4000× g and 4 • C for 20 min. The cells were suspended in lysis buffer (20 mM Tris-HCl (pH 8.0), 100 mM NaCl, 10 mM imidazole, 0.50 mg/mL lysozyme, and 1.2 U/mL DNase I). Subsequently, the cells were disrupted by sonication using 70% amplitude, 0.5 s on/off, for 7 min, and the resulting cell lysate was centrifuged at 40,000× g and 4 • C for 30 min. The supernatant was loaded onto a Ni-nitrilotriacetic acid (Ni-NTA) column (bed volume 2 mL), washed and eluted sequentially by wash buffer 1 (20 mM Tris-HCl (pH 8.0), 100 mM NaCl, and 10 mM imidazole), wash buffer 2 (wash buffer 1 supplemented with 20 mM imidazole), elution buffer 1 (wash buffer 1 with 50 mM imidazole), elution buffer 2 (wash buffer 1 with 100 mM imidazole), elution buffer 3 (wash buffer 1 with 150 mM imidazole), and elution buffer 4 (wash buffer 1 with 250 mM imidazole). Based on the sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) data, all fractions containing 6× His-tev-VmFbpA were collected and stored at 4 • C before use.

Preparation of 6× His-tag-free VmFbpA
A total of 6× His-tev-VmFbpA were dialyzed overnight against lysis buffer at 4 • C to lower the imidazole concentration. The 6× His-tag was cleaved by adding 6× His-TEV protease (homemade, 10 units/mg protein). Then, the reaction mixture was reloaded on the Ni-NTA column and the eluent, which contained mainly 6× His-tag-free VmFbpA, and was collected and concentrated with a Vivaspin 20 (MWCO 10 K, Sartorius) to a protein concentration of approximately 1.5 mg/mL. Then, the sample was loaded onto a Superdex 200 10/300 GL column (GE Healthcare) and separated using gel filtration buffer A (20 mM Tris-HCl (pH 8.0) and 100 mM NaCl) using an ÄKTA purifier (GE Healthcare) for the final purification. Protein samples were adjusted to a final protein concentration of 0.3 mM by ultrafiltration using a Vivaspin 20 (MWCO 10 K, Sartorius) and stored at 4 • C.

Preparation of Fe 3+ -VmFbpA and Apo VmFbpA
To form Fe 3+ -bound VmFbpA, ferric chloride hexahydrate (FeCl 3 ·6H 2 O) was added to purified VmFbpA to a final concentration of 4.2 mM. Next, EDTA at a final concentration of 10 mM was added to form apo VmFbpA. The samples were incubated with 50 mM sodium bicarbonate (NaHCO 3 ) at 4 • C for 20 h and then concentrated to a protein concentration of approximately 0.7 mg/mL. Each sample was loaded onto a Superdex 200 10/300 GL column and separated using gel filtration buffer (50 mM Tris-HCl (pH 8.0), 50 mM NaHCO 3 , and 150 mM NaCl). Fractions were collected according to the peak measured at 280 nm. The samples were adjusted to a final protein concentration of 0.1 mM by ultrafiltration using a Vivaspin 20 (MWCO 10 K) and stored at 4 • C. 150 mM NaCl, and 250 mM imidazole). The Fe concentration of eluent was determined by ICP-MS as reported previously [19] and adjusted to the protein concentration (measured using a Pierce 660 nm Protein Assay, Thermo Fisher Scientific) in the eluent. Samples without FeCl 3 were used as the negative control group, and samples lacking rosemary extract or RA as the positive control group. Unless indicated, all buffers contained 0.3% dimethyl sulfoxide (DMSO) [35] to solubilize RA.

Determination of the 50% Inhibitory Concentration
Rosemary extracts and RA were used to evaluate VmFbpA inhibitory activity. Twohundred microliters of rosemary extracts (1.56 to 25.0 mg/mL) and RA (2.34 µg/mL to 2.40 mg/mL), with a two-fold dilution gradient were performed. Apo VmFbpA was used as the negative control and Fe 3+ -VmFbpA lacking RA was used as the positive control. The Fe concentration of the eluents was determined by ICP-MS as reported previously [19]. The inhibitory rates were calculated as below: The inhibitory rate was plotted in a scatter plot as a function of RA concentration and fitted by a logarithmic function model. The 50% inhibitory concentration (IC 50 ) was calculated by reading the RA concentration at the inhibitory rate is 50%.

Spectral Analysis of VmFbpA Interacting with Rosemary Extracts and RA
Rosemary extracts (15 to 0.9 mg/mL, with a two-fold dilution gradient) and 200 µL 0.3 mM apo 6× His-tev-VmFbpA with 3 mM FeCl 3 were used in a pull-down assay to assess the interaction between Fe 3+ -VmFbpA and RA.
RA (2.4 to 0.15 mg/mL, with a two-fold dilution gradient) and 200 µL 0.3 mM apo 6× His-tev-VmFbpA without FeCl 3 were used in the pull-down assay to assess the interaction between apo VmFbpA and RA.
The absorbance spectra of the eluents at 300-700 nm were measured using a UV-vis spectrophotometer (JASCO V-630) at room temperature. Samples without FeCl 3 and RA were used as the negative controls and samples lacking RA were used as the positive control. Samples without preloading of apo 6× His-tev-VmFbpA were used to determine the background.

Analysis of RA on Fe 3+ Reduction
Solutions of 40 µM FeCl 3 supplemented with 0, 0.625, 1.25, 5, 10, 20, and 40 µM RA were used for analysis. First, 0.25% o-phenanthroline (2 mL) was added to each sample, and the pH was adjusted to 3.5 with hydrochloric acid (HCl). Milli-Q water was added to a final volume of 25 mL. After 1 h incubation, the absorbance at 510 nm was measured using a microplate spectrophotometer (Benchmark Plus, Bio-Rad). The concentration of Fe 2+ was quantified using ferrous sulfate heptahydrate (FeSO 4 ·7H 2 O) as the standard. The buffers did not contain DMSO.

ITC Analysis
The 6× His-free apo/Fe 3+ VmFbpA samples were dialyzed overnight at 4 • C against dialysis buffer (20 mM Tris-HCl (pH 8.0), 25 mM NaHCO 3 , and 50 mM NaCl, 20 mM imida-zole, 0.3% DMSO). ITC was performed using MicroCal iTC200 (Malvern). RA (0.5 mM) or Fe 3+ (0.1 mM) diluted in dialysis buffer was injected 20 times by a motor-driven syringe into 200 µL 0.01 mM Apo VmFbpA. The first injection volume was 0.1 µL, and the subsequent injection volumes were 2.0 µL. The solution in the titration cell was stirred at 750 rpm throughout the experiment. In addition, titration of RA (0.5 mM) into Fe 3+ -VmFbpA (0.1 mM) was performed as described above. The reference cell of the microcalorimeter was filled with 200 µL of the corresponding dialysis buffer. The titrations were performed at room temperature. The data were analyzed by MicroCal LLC iTC 200 for Windows (Malvern).

Crystallization and X-ray Diffraction Data Collection
Initial crystallization screening was performed in 96-well Violamo Protein Crystallization Plates (As One) using commercially available kits, namely Crystal Screen HT, Index HT (Hampton Research), and Wizard I and II (Emerald BioSystems) at 293 K. A crystallization drop was prepared by mixing 0.5 µL protein solution and 0.5 µL reservoir solution and was equilibrated against 40 µL reservoir solution. After two-dimensional grid optimization of the crystallization conditions (pH versus precipitant concentration), they were further optimized by the sitting-drop vapor-diffusion method in 24-well Cryschem Plates (Hampton Research). A crystallization drop was prepared by mixing 1.0 µL protein solution and 1.0 µL reservoir solution and was equilibrated against 500 µL reservoir solution.
Crystals of apo VmFbpA were obtained using a reservoir composition of 0.25 M ammonium tartrate dibasic, 25% PEG3350, 100 mM Tris-HCl (pH 7.0). Each crystal was picked up in a mounting loop and cooled in a cold nitrogen-gas stream using a cryoprotectant consisting of 0.25 M ammonium tartrate dibasic, 25% PEG3350, 100 mM Tris-HCl (pH 7.0), and 20% (v/v) glycerol. X-ray diffraction experiments for apo VmFbpA crystals were performed on beamlines BL44XU at SPring-8 (Hyogo, Japan) and AR-NE3A at Photon Factory (Ibaraki, Japan). The final data set was collected from an apo VmFbpA crystal at a wavelength of 0.899995 Å, a crystal-to-detector distance of 319.90 mm, an oscillation angle of 0.1 • , and an exposure time of 0.1 s per image using an EIGER 16M detector at BL44XU at SPring-8. The structure solution and refinement were described in the Supplementary Information.

Docking Simulation
The crystal structure of apo VmFpbA solved in this study was used as the template. Docking simulation analysis was performed on a Linux (CentOS 7.0) platform using AutoDock (version Vina 1.1.2) [36]. Three areas were selected (N-terminus, C-terminus, and the Fe 3+ -binding site) ( Figure S5a) as the docking cavities for the grid box to cover. The 3D model of RA ( Figure S5b) was created by ChemBioDraw Ultra (version 13.0.0.3015) and optimized by AutoDockTools (version 1.5.4). The default mode was used.

Inhibition by RA of V. metschnikovii Growth
The glycerol stock of V. metschnikovii was prepared by culturing the bacteria in NB liquid medium (meat extract 3.0 g/L, meat peptone 5.0 g/L, NaCl 10.0 g/L, at pH 7.0) and flash freezing in liquid nitrogen after adding 50% glycerol (1:1, v/v) at the OD 600 of 0.6. Next, 10 µL V. metschnikovii cell from the glycerol stock were added to 10 mL NB medium containing 0.3% DMSO and 1000, 500, 100, 50, 25, and 0 µM RA. The culture was performed at 37 • C. The optical density at 600 nm was monitored every h (0-10 h) by a microplate spectrophotometer (Benchmark Plus, Bio-Rad).

Inhibition of E. coli Growth by RA
A glycerol stock of E. coli (BL21(DE3) or KRX) was prepared by culturing the bacteria in NB medium and flash freezing in liquid nitrogen after adding 50% glycerol (1:1, v/v) to an OD 600 of 0.6. E. coli (BL21(DE3) or KRX) (10 µL) from the glycerol stock was added to 10 mL NB medium containing 0.3% DMSO and 1000, 500, 100, 50, 25, and 0 µM RA. The culture was performed at 37 • C. The optical density at 600 nm was monitored every hour (0-10 h) by a microplate spectrophotometer (Benchmark Plus, Bio-Rad).

Measurement of Iron Utilization by V. metschnikovii
V. metschnikovii (10 µL) from the glycerol stock were added to 10 mL NB medium containing 0.3% DMSO and 1000, 500, 100, 50, 25, and 0 µM RA. The culture was performed at 37 • C for 7 h followed by centrifugation at 40,000 g for 15 min. The weight of precipitate (V. metschnikovii) was measured using a precision balance. The remaining iron in supernatant was measured using ICP-MS as reported previously [19]. The Fe utilization ratio was calculated as: Fe utilization ratio µmol·L −1 ·g -1 = Fe Conc,BK -Fe Conc,Remian m vibrio × V where Fe Conc,BK is the original iron concentration in NB medium, Fe Conc,Remain is the remaining iron concentration after culture of V. metschnikovii, m vibrio is the weight of V. metschnikovii after culture, and V is the volume of NB medium.

Recovery of V. metschnikovii by Supplementation of Fe 3+
V. metschnikovii (10 µL) from the glycerol stock was added to 10 mL NB medium containing 1000 µM RA with 10 and 50 µmol FeCl 3 , respectively. The positive control group was V. metschnikovii without supplementation of RA and FeCl 3 . The negative control group was V. metschnikovii without FeCl 3 . Culture was performed at 37 • C. The optical density at 600 nm was monitored every hour (0-10 h) by a microplate spectrophotometer (Benchmark Plus, Bio-Rad).

Inhibition by RA and SC of the Growth of V. metschnikovii
V. metschnikovii (10 µL) from the glycerol stock was added to 10 mL of NB medium supplemented with RA and SC. Culture was performed at 37 • C for 7 h. Optical density at 600 nm was measured using a microplate spectrophotometer (Benchmark Plus, Bio-Rad).
4.19. Inhibition by RA and SC of the Growth of E. coli E. coli (BL21(DE3) or KRX) (10 µL) from the glycerol stock was added to 10 mL NB medium supplemented with RA and SC. Culture was performed at 37 • C for 7 h. The optical density at 600 nm was measured using a microplate spectrophotometer (Benchmark Plus, Bio-Rad).

Inhibition by RA and SC of the Growth of V. vulnificus and V. parahaemolyticus
Glycerol stocks of V. vulnificus and V. parahaemolyticus were prepared as for V. metschnikovii. Cells (10 µL) from the glycerol stock were added to 10 mL NB medium supplemented with RA and SC. Culture was performed at 37 • C for 7 h. The optical density at 600 nm was measured using a microplate spectrophotometer (Benchmark Plus, Bio-Rad).

Statistical Analysis
The statistical significance was analyzed by one-way ANOVA followed by a Tukey HSD (honestly significant difference) post hoc test using R program (Version 3.6.0). p ≤ 0.05 was considered to be statistically significant.

Conclusions
The advent of multidrug resistance among pathogenic bacteria is imperiling the utility of antibiotics. The inhibition of FbpA and iron uptake shows promise as an antibacterial. In this study, we have revealed the molecular mechanism of anti-Vibrio activity of RA. The growths of V. metschnikovii, V. vulnificus, and V. parahaemolyticus were inhibited significantly by RA and further inhibited by the supplementation of SC. The combination of RA and SC has high potential to be applied as a food preservative and bacteriostatic agent in the future. Moreover, such new bacteriostatic agents will reduce the excessive and inappropriate use of antibiotics in livestock, aquaculture, and plant agriculture as well as human and veterinary medicine. Further studies should evaluate the utility of RA/SC in various areas.